Roselyne Omwega v. HHS - Influenza, Guillain-Barre syndrome (GBS) (2026)
Case summary [AI summaries can sometimes make mistakes]
On May 14, 2024, Roselyne Omwega filed a petition alleging that she developed Guillain-Barre syndrome after receiving an influenza vaccine on November 2, 2023. Respondent conceded entitlement in a Rule 4(c) report.
The concession stated that Ms. Omwega satisfied the Vaccine Injury Table criteria for GBS after seasonal flu vaccination, including onset between three and forty-two days after vaccination and no apparent alternative cause.
The short public ruling does not state her exact age, first neurologic symptom, hospitalization, lumbar puncture or nerve testing, treatment, rehabilitation, or residual limitations. On January 30, 2026, Chief Special Master Brian H.
Corcoran found Ms. Omwega entitled to compensation.
Damages had not yet been resolved in the public ruling. Ms.
Omwega was represented by Alison Haskins of Siri & Glimstad, LLP.
Theory of causation
Influenza vaccine on November 2, 2023 causing Table GBS; adult self-filed petitioner, exact age not stated. ENTITLEMENT CONCEDED; damages pending. Rule 4(c) concession: GBS onset within 3-42 day Table window and no apparent alternative cause. Public ruling lacks detailed onset/hospital/diagnostic/treatment/rehab facts. Chief SM Brian H. Corcoran; petition May 14, 2024; decision January 30, 2026. Attorney Alison Haskins.
Source PDFs
USCOURTS-cofc-1_24-vv-00752